Help shape the future of anti- ageing skincare
You are invited to participate in a groundbreaking genetic anti-ageing research project at Imperial College London. Recruiting male and female non-smoking volunteers aged 35-65.
The aim of this study is to look at how your genetics can play a role in informing you about the skin-care products that are suitable and effective for you. There are many skin-care products available on the market today, most making claims about their active ingredients and how they may improve skin texture and reduce the appearance of fine lines. With so many products available, it can be difficult and even bewildering to decide which product to choose. Unlike for example, buying a mobile phone where it is often easy to follow the best recommendation of friends and family, with skin-care products, what works well for one person may not work as well with another. One of the key reasons for this lies in how we are all different and unique. This study is looking at genes, which we believe might be implicated in this intrinsic ageing process.
The pre-selection:
We would like to invite you to attend a short walk-in session at Imperial College in South Kensington to provide a saliva sample and complete a short questionnaire. This should not take more than 15 min. This sample will determine whether or not you can partake in the trial, as we will analyse genes in the saliva that impact how skin ages. We anticipate half of invited person will then be eligible for the full trial. The dates for the initial eligibility screening will be between the 4th and 26th of April. A variety of times will be available for you to attend and these can be arranged to suit you.
The trial:
If selected you will then be invited to partake in the full trial, which will involve you applying a dermatologically tested anti-ageing serum specifically designed for your skin for 12 weeks. This trial will require you to attend 3 x 45 minute sessions at Imperial College for visual and photographic skin assessment. At the end of the trial subjects will receive an incentive for their participation. The dates for the 3 assessment sessions are 10-12 May, 21-23 June and 2-4 August.
Please email Dr. Belinda Nedjai at b.nedjai@imperial.ac.uk if you would like to attend the trial or have any questions regarding recruitment or the trial itself.
geneOnyx™ is working with The Organic Pharmacy to launch the world’s first in store DNA test
Margo Marrone, founder of The Organic Pharmacy, has partnered with world-leading medical technology pioneer Professor Chris Toumazou from Imperial College London to exclusively launch the world’s first in-store DNA test. The test provides a genetically tailored anti-ageing skincare product recommendation service with over the counter results.
Most DNA tests require laboratory processing with results taking weeks to process. Now however, through geneOnyx, a revolutionary instant DNA detection technology service has been created, delivering results in just 30 minutes. The DNA test technology is licensed to geneOnyx by DNA Electronics, a spin out of Imperial College London (reference March Press Release) (more…)
DNA Electronics CEO Professor Chris Toumazou Invited To Present At UKTI’s Healthcare and Life Sciences Global Business Summit
Vision for “Disposable Semiconductor Healthcare – From the bedside to point of care genetics” To Be Shared at UKTI Seminar (London, 2nd August 2012)
London, United Kingdom, July 24 2012 – DNA Electronics Ltd, a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that DNA Electronics Chairman and CEO Professor Chris Toumazou FRS will be sharing his vision for the future of the life sciences sector at the upcoming Healthcare and Life Sciences Global Business Summit being hosted by UK Trade & Investment (UKTI) at Lancaster House in London on Thursday 2nd August 2012. Professor Toumazou will join other key innovators, dignitaries and industry figures from the UK life sciences community who have been invited to address delegates on the future of the sector. (more…)
